Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis.

MLA

Abassi, Mahsa, et al. “Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis.” Clinical Infectious Diseases, vol. 73, no. 9, Nov. 2021, pp. e3077–82. EBSCOhost, https://doi.org/10.1093/cid/ciaa1749.

APA

Abassi, M., Bangdiwala, A. S., Nuwagira, E., Tadeo, K. K., Okirwoth, M., Williams, D. A., Mpoza, E., Tugume, L., Ssebambulidde, K., Hullsiek, K. H., Musubire, A. K., Muzoora, C., Rhein, J., Meya, D. B., & Boulware, D. R. (2021). Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis. Clinical Infectious Diseases, 73(9), e3077–e3082. https://doi.org/10.1093/cid/ciaa1749

Chicago

Abassi, Mahsa, Ananta S Bangdiwala, Edwin Nuwagira, Kiiza Kandole Tadeo, Michael Okirwoth, Darlisha A Williams, Edward Mpoza, et al. 2021. “Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis.” Clinical Infectious Diseases 73 (9): e3077–82. doi:10.1093/cid/ciaa1749.